Senomyx Inc (SNMX) 5.50 $SNMX Senomyx, Inc. First

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Senomyx Inc (SNMX) 5.50 $SNMX

Senomyx, Inc. First Quarter 2015 Earnings Conference Call Scheduled for April 30, 2015
GlobeNewswire - Wed Apr 22, 7:30AM CDT
Senomyx, Inc. (Nasdaq:SNMX) will release its financial results for the first quarter ended March 31, 2015 on Thursday, April 30, 2015, before the opening of the U.S. financial markets. The Company will also host a conference call with a live Internet broadcast that will provide a corporate update and a review of its first quarter results on the same day at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time).
SNMX: 5.50 (-0.02)

Senomyx Down 28.6% Since SmarTrend Downtrend Call (SNMX)
Comtex SmarTrend(R) - Fri Apr 10, 9:45AM CDT
SmarTrend identified a Downtrend for Senomyx (NASDAQ:SNMX) on October 10th, 2014 at $7.04. In approximately 6 months, Senomyx has returned 28.55% as of today's recent price of $5.03.
SNMX: 5.50 (-0.02)

SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 14TH ANNUAL NEEDHAM HEALTHCARE CONFERENCE
PR Newswire - Wed Apr 08, 4:00PM CDT
Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and flavor industries, announced today that John Poyhonen, the Company's President and Chief Executive Officer, and Tony Rogers, Senior Vice President and Chief Financial Officer, will present an overview of Senomyx's technology and programs on Tuesday, April 14, at 2:20 p.m. Eastern Time (11:20 a.m. Pacific Time) during the 14th Annual Needham Healthcare Conference. The conference is taking place at the Westin Grand Central Hotel in New York, NY. During the presentation, Mr. Poyhonen and Mr. Rogers will discuss corporate developments including the Company's novel flavor ingredients and its business strategy.
SNMX: 5.50 (-0.02)

After Hours Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 4:36PM CST

SGYP: 4.01 (-0.10), VNDA: 9.97 (-0.12), SALT: 2.48 (+0.14), ENOC: 11.39 (+0.12), SPPI: 6.10 (+0.07), RNDY: 5.52 (+0.02), DAR: 13.84 (-0.08), SNMX: 5.50 (-0.02), OMER: 24.32 (-0.35), SMTC: 23.60 (-1.90)

Hot Stock: Senomyx, Shares Drop 7.7% (SNMX)
Comtex SmarTrend(R) - Mon Mar 02, 11:33AM CST
Senomyx (NASDAQ:SNMX) is one of today's worst performing low-priced stocks, down 7.7% to $4.91 on 1.1x average daily volume. Senomyx has traded 301,000 shares thus far today, vs. average volume of 263,000 shares per day. The stock has underperformed the Dow (-7.7% to the Dow's 0.5%) and underperformed the S&P 500 (-7.7% to the S&P's 0.2%) during today's trading.
SNMX: 5.50 (-0.02)

Nasdaq stocks posting largest percentage decreases
AP - Fri Feb 27, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
RESN: 3.90 (+0.06), PEGA: 22.35 (+0.13), IQNT: 19.31 (+0.94), PFMT: 3.22 (-0.04), HAWKB: 35.47 (-0.04), STAA: 9.14 (+0.02), LKQ: 25.58 (unch), VTAE: 14.05 (+0.12), BDBD: 10.14 (-0.05), HAWK: 35.67 (-0.03), RMTI: 10.37 (-0.23), PLKI: 59.22 (+2.06), ANIK: 38.35 (-0.32), TASR: 29.67 (-0.01), SNMX: 5.50 (-0.02)

Senomyx (SNMX) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 26, 3:10PM CST

SNMX: 5.50 (-0.02)

Senomyx's (SNMX) CEO John Poyhonen on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 26, 2:11PM CST

SNMX: 5.50 (-0.02)

Senomyx reports 4Q loss
Automated Insights - Thu Feb 26, 10:39AM CST
SAN DIEGO (AP) _ Senomyx Inc. (SNMX) on Thursday reported a loss of $3.1 million in its fourth quarter.
SNMX: 5.50 (-0.02)

Senomyx beats by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 7:32AM CST

SNMX: 5.50 (-0.02)

Senomyx Has Returned 16.6% Since SmarTrend Recommendation (SNMX)
Comtex SmarTrend(R) - Tue Feb 17, 11:08AM CST
SmarTrend identified a Downtrend for Senomyx (NASDAQ:SNMX) on October 10th, 2014 at $7.04. In approximately 4 months, Senomyx has returned 16.62% as of today's recent price of $5.87.
SNMX: 5.50 (-0.02)

Senomyx, Inc. Fourth Quarter and Fiscal Year-End 2014 Earnings Conference Call Scheduled for February 26, 2015
GlobeNewswire - Thu Feb 12, 7:30AM CST
Senomyx, Inc. (Nasdaq:SNMX) will release its financial results for the fourth quarter and fiscal year ended December 31, 2014 on Thursday, February 26, 2015, before the opening of the U.S. financial markets. The Company will also host a conference call with a live Internet broadcast that will provide a corporate update and a review of its fourth quarter and year-end results on the same day at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time).
SNMX: 5.50 (-0.02)

Shares of SNMX Down 21.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Feb 09, 9:46AM CST
SmarTrend identified a Downtrend for Senomyx (NASDAQ:SNMX) on October 10th, 2014 at $7.04. In approximately 4 months, Senomyx has returned 21.59% as of today's recent price of $5.52.
SNMX: 5.50 (-0.02)

Commit To Purchase Senomyx At $5, Earn 24.5% Annualized Using Options
at The Street - Thu Feb 05, 11:14AM CST
Investors considering a purchase of Senomyx Inc stock, but cautious about paying the going market price of $5.11/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in...
SNMX: 5.50 (-0.02)

Senomyx Shares Down 25.0% Since SmarTrend's Sell Call (SNMX)
Comtex SmarTrend(R) - Mon Feb 02, 9:19AM CST
SmarTrend identified a Downtrend for Senomyx (NASDAQ:SNMX) on October 10th, 2014 at $7.04. In approximately 4 months, Senomyx has returned 25.00% as of today's recent price of $5.28.
SNMX: 5.50 (-0.02)

21.7% Return Seen to Date on SmarTrend Senomyx Call (SNMX)
Comtex SmarTrend(R) - Fri Jan 23, 4:51PM CST
SmarTrend identified a Downtrend for Senomyx (NASDAQ:SNMX) on October 10th, 2014 at $7.04. In approximately 4 months, Senomyx has returned 21.73% as of today's recent price of $5.51.
SNMX: 5.50 (-0.02)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 52

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 40

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 28

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 63

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 46

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 35

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 37

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Supply Crunch from CATL's Decision Triggers Lithium Market Rally

Updated Category News Views 98

CATL's Halt of Lithium Production Shakes Up the Market Recently, CATL grabbed attention by stopping operations at a significant lithium production site. This move, officially confirmed by the company, was a response to shifting conditions in the lithium carbonate market, particularly in Yichun. Effects on Lithium Supply and Pricing As a result of this suspension, China's...

Continue Reading
Cohen & Steers Fund Distribution Insights and Performance Update

Updated Category News Views 216

Understanding Distribution Sources for Cohen & Steers Fund Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) has provided vital information regarding the sources of its distributions. The fund aims to keep its shareholders well-informed about the dividends expected in the upcoming payment period. The Managed Distribution Policy Explained The fund's investment...

Continue Reading
SiteOne Landscape Supply: Insider Sell Raises Questions

Updated Category News Views 171

February 17 was a noteworthy date for SiteOne Landscape Supply (NYSE:SITE) as insider Eric Elema, the company's EVP, made waves with a substantial stock sale of 1,765 shares amounting to $278,887. Insider selling can often send mixed signals to the market; while it might raise eyebrows about internal confidence, it doesn’t always equate to a bearish sentiment on the...

Continue Reading
ArcBest Outlines Growth Strategies and Financial Goals for 2028

Updated Category News Views 244

ArcBest's Vision for Future Growth ArcBest is committed to a future of logistics excellence, emphasizing a strategy built on growth, efficiency, and innovation. At the recent investor day, the leadership team provided a roadmap for the company's journey towards ambitious financial targets set for 2028. Integrating Technology for Superior Logistics Solutions As a leading...

Continue Reading
Barolo and Barbaresco Academy Roadshow: A Wine Journey

Updated Category News Views 131

Barolo and Barbaresco Academy Roadshow Celebrates Success The Academy Roadshow recently concluded with a series of sold-out seminars across multiple cities in the Southwest, showcasing an increasing interest in Barolo and Barbaresco wines. This event gathered wine professionals and enthusiasts eager to deepen their understanding of these exceptional wines. Highlights of...

Continue Reading